Report published on JAMA Neurology showing
that increased cerebrospinal fluid neurofilament light proteins and
reduced amyloid β were observed in patients with postconcussion syndrome (PCS).
They suggest the measurement of these
biomarkers may be an objective tool to assess the degree of central
nervous system injury in individuals with PCS and to distinguish
individuals who are at risk of developing chronic traumatic
encephalopathy.
Read the full reports @ JAMA Neurology.
No comments:
Post a Comment